Scientific & Medical Advisors
Gregory Jay, MD, PhD – Co-Founder and Senior Medical Advisor – is a Professor of Emergency Medicine, Medicine and Engineering at Brown Medical School, an attending physician at Rhode Island Hospital and Chief Medical Officer of Tribologics, LLC. Dr. Jay was appointed to the position of Associate Chair for Research in the Department of Emergency Medicine as of July 2006. Dr. Jay was former recipient of the Bruce M. Selya Award in 2004. for Research Excellence. Dr. Jay has published over 30 scientific articles on the characterization and function of Lubricin.
Tannin Schmidt, Ph.D. – Co-Founder and Senior Scientific Consultant – is an Associate Professor in the Faculty of Kinesiology and Schulich School of Engineering at the University of Calgary, Canada. He holds a Canada Research Chair in Biomedical Engineering – Biomaterials, and is one of North America’s leading experts in Lubricin metabolism and boundary lubrication.
David Sullivan, Ph.D. – Co-Founder and Senior Scientific Advisor – is an Associate Professor in the Department of Ophthalmology at Harvard Medical School and a Senior Scientist at the Schepens Eye Research Institute. Over the past 32 years, his research has focused on endocrine and immune interactions in the eye, with a particular emphasis on Dry Eye Disease with over 200 published scientific articles. Dr. Sullivan is also a Founder, recent President and current Chairman of the Board of the Tear Film & Ocular Surface Society (TFOS), which was created to advance the research, literacy, and educational aspects of the scientific field of the tear film and ocular surface around the world.
Benjamin Sullivan, Ph.D. – Co–Founder, Scientific Advisor and Board Member – is a co-founder and CSO of TearLab Corp., a publicly traded medical device company focusing on point of care diagnostics for Dry Eye Disease. At TearLab, Dr. Sullivan has designed and executed dozens of Dry Eye clinical trials. Prior to obtaining his Ph.D. in Bioengineering at the University of California, San Diego, Benjamin spent six years researching effects of Dry Eye Disease on molecular profiles of the tear film while at the Schepens Eye Research Institute affiliate of Harvard Medical School.